Literature DB >> 27478779

Evaluating Effect of Mesenchymal Stem Cells on Expression of TLR2 and TLR4 in Mouse DCs.

Mohammad Hossein Karimi1, Zahra Barzkar2, Maryam Babaee1, Majid Naghdi3.   

Abstract

PURPOSE: Mesenchymal stem cells (MSCs) are multipotent cells and recent findings suggest immunomodulatory effect of them on immune cells including T cells and dendritic cells (DCs). DCs are the most potent antigen presenting cells. It seems because of immunoregulatory properties of MSCs, they can affect the maturation and differentiation of DCs. DCs express a kind of surface receptors called toll-like receptors (TLRs) and play a key role in maturation process and activation of DCs. The aim of this study was to evaluate expression of TLR2 and TLR4 on DCs after exposure to mesenchymal stem cell's supernatant in culture media containing LPS and devoid of it.
METHODS: In this experimental study, MSCs and DCs were extracted from adult Balb/c mouse bone marrow and spleen, respectively. MSCs supernatant were collected 24 and 48 h after 5(th) passage, and in adjusted with DCs culture. Isolated DCs were co-cultured with MSCs supernatant, incubation time were 24 and 48 hours. mRNA levels of TLR2 and TLR4 were evaluated using real time PCR technique.
RESULTS: The results demonstrated that although, expressions of these two receptors were up-regulated in culture media lacking LPS in comparison with the control group but the increase was not significant. There were no significant associations between LPS stimulated DCs with and without MSCs supernatants.
CONCLUSION: According to the results presented here, it appears that TLR2 and TLR4 gene expressions on the DCs are not affected by MSCs supernatant.

Entities:  

Keywords:  Dendritic cells; Immunomodulation; Mesenchymal stem cells; Toll like receptors

Year:  2016        PMID: 27478779      PMCID: PMC4961975          DOI: 10.15171/apb.2016.025

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  43 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  An in vitro assay to evaluate the immunomodulatory effects of unrestricted somatic stem cells.

Authors:  Hasan Ebrahimi; Masoud Soleimani; Mohammad Kazemi Arababadi; Naser Ahmadbeigi; Gholamhossein Hassanshahi; Akbar Farjadfar; Derek Kennedy
Journal:  Iran J Immunol       Date:  2010-03       Impact factor: 1.603

Review 3.  Mechanisms of mesenchymal stromal cell immunomodulation.

Authors:  Karen English
Journal:  Immunol Cell Biol       Date:  2012-10-23       Impact factor: 5.126

Review 4.  Immunomodulatory properties and therapeutic application of mesenchymal stem cells.

Authors:  M Shi; Z-W Liu; F-S Wang
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

Review 5.  Immunomodulatory effect of mesenchymal stem cells.

Authors:  C Herrero; J A Pérez-Simón
Journal:  Braz J Med Biol Res       Date:  2010-04-23       Impact factor: 2.590

6.  Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.

Authors:  Soufiane Ghannam; Carine Bouffi; Farida Djouad; Christian Jorgensen; Danièle Noël
Journal:  Stem Cell Res Ther       Date:  2010-03-15       Impact factor: 6.832

7.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

Authors:  Grazia Maria Spaggiari; Heba Abdelrazik; Flavio Becchetti; Lorenzo Moretta
Journal:  Blood       Date:  2009-04-27       Impact factor: 22.113

8.  Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.

Authors:  Farida Djouad; Louis-Marie Charbonnier; Carine Bouffi; Pascale Louis-Plence; Claire Bony; Florence Apparailly; Céline Cantos; Christian Jorgensen; Danièle Noël
Journal:  Stem Cells       Date:  2007-05-17       Impact factor: 6.277

9.  Decreased expressions of Toll-like receptor 9 and its signaling molecules in chronic hepatitis B virus-infected patients.

Authors:  Seyyed Mohammad Ali Sajadi; Vahid Mirzaei; Gholamhossein Hassanshahi; Hossein Khorramdelazad; Hassan Yousefi Daredor; Seyyed Mohammad Hossein Hosseini; Mojgan Moogooi; Ali Ravary; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Arch Pathol Lab Med       Date:  2013-11       Impact factor: 5.534

Review 10.  Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation.

Authors:  Giuseppe Vassalli
Journal:  J Transplant       Date:  2013-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.